Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01939717
Other study ID # ST2
Secondary ID
Status Completed
Phase N/A
First received August 25, 2013
Last updated May 30, 2016
Start date August 2013
Est. completion date January 2016

Study information

Verified date May 2016
Source University of Limerick
Contact n/a
Is FDA regulated No
Health authority Ireland: Research Ethics Committee
Study type Interventional

Clinical Trial Summary

Primary aim is to conduct a pilot trial to determine:

1. The feasibility and efficiency of randomisation procedures and study design

2. If recruitment rates are sufficient to adequately power a larger trial

The secondary aim is to determine the efficiency of set dancing in comparison to a control for people with Patkinson's disease.


Recruitment information / eligibility

Status Completed
Enrollment 90
Est. completion date January 2016
Est. primary completion date January 2016
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Have a diagnosis of idiopathic Parkinson's disease (Hackney et al 2007; Marchant et al 2010), stage 1-2.5 on the modified Hoeln and Yahr scale for staging of Parkinson's disease (Batson 2010)

- Able to walk three meters with an assistive device

- Over 18 years of age

- Not pregnant

- Have access to a computer/DVD player to allow them to participate in the home exercise programme

Exclusion Criteria:

- A serious cardiovascular and/or pulmonary condition (Lodder et al 2004)

- A neurological deficit other than Parkinson's disease (Batson 2010; Marchant et al 2010)

- Evidence of a musculoskeletal problem (Duncan and Earhart 2012), contraindicating participation in exercise participation(Lodder et al 2004)

- A cognitive or hearing problem which will affect their ability to follow instructions or hear the music (Batson 2010)

- Participated in regular dance classes in the past six months (Marchant et al 2010)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Other:
Dance group
Participants will attend ten weeks of set dancing classes. Each class will be one and half hours. Family members will be invited to partner each participant with Parkinson's disease during the class. Set dancing steps and sets will be thought and progressed in line with the participants abilities. Frequent rests will be taken during the classes. Participants will be given a home exercise programme which will involve chair based exercises, mental rehearsal, listening music, watching a dance DVD and practicing dance material thought in class.

Locations

Country Name City State
Ireland University of Limerick Limerick Munster

Sponsors (1)

Lead Sponsor Collaborator
University of Limerick

Country where clinical trial is conducted

Ireland, 

References & Publications (3)

Duncan RP, Earhart GM. Randomized controlled trial of community-based dancing to modify disease progression in Parkinson disease. Neurorehabil Neural Repair. 2012 Feb;26(2):132-43. doi: 10.1177/1545968311421614. Epub 2011 Sep 29. — View Citation

Heiberger L, Maurer C, Amtage F, Mendez-Balbuena I, Schulte-Mönting J, Hepp-Reymond MC, Kristeva R. Impact of a weekly dance class on the functional mobility and on the quality of life of individuals with Parkinson's disease. Front Aging Neurosci. 2011 Oct 10;3:14. doi: 10.3389/fnagi.2011.00014. eCollection 2011. — View Citation

Marchant D, Sylvester JL, Earhart GM. Effects of a short duration, high dose contact improvisation dance workshop on Parkinson disease: a pilot study. Complement Ther Med. 2010 Oct;18(5):184-90. doi: 10.1016/j.ctim.2010.07.004. Epub 2010 Aug 21. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility of randomization procedures (To assess implementation of randomization procedures) This outcome measure will be assessed over a 1 year period from study inception to completion No
Primary Attrition (To assess dropout rate during the study) Attrition rate of = 20% per group will be deemed acceptable This outcome measure will be assessed over a 1 year period from study inception to completion No
Primary Intervention adherence (To assess compliance with the dance intervention) 2) Intervention will be considered successful if no adverse effects or safety issues are reported and attendance at classes is =70% This outcome will be assessed during the 10 week set dancing intervention No
Primary Recruitment rates (To assess rate, duration and success of recruitment methods) Recruitment considered successful and feasible is 100 participants are recruited in one year This outcome will be assessed over a one year recruitment period No
Primary Resources (To assess availability of personnel and building needed to implement study methodology) Document issues regarding availability of personnel or buildings needed to implement study methodology This outcome measure will be assessed over a 1 year period from study inception to completion No
Secondary Exit Questionnaire (To assess participants satisfaction) The exit questionnaire will assess participants' satisfaction with the dance intervention at the end of the study. The questionnaire asks participants if they have noted improvements in different aspects of physical well-being, and allows feedback relating to the structure, material and enjoyment of the dance classes to be gathered. This questionnaire has previously been used in other studies investigating the benefit of dance for those with Parkinson's disease (Hackney and Earhart 2009; Hackney and Earhart 2010). This outcome will be assessed the week after the intervention period ends. No
Secondary The Parkinson's Disease Questionnaire (PDQ-39) (To assess change in health related quality of life) Self-report quality of life questionnaire This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends No
Secondary Unified Parkinson's Disease Rating Scale 3 (UPDRS-3) (To assess changes in motor impairment) Disease specific measure of motor function This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends No
Secondary Six minute walk test (To assess change in functional endurnace) Measure of functional endurance This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends No
Secondary MiniBESTest (To asses change in balance) Balance measure This outcome will be assessed within a week before the intervention begins and within a week after the intervention period ends No
See also
  Status Clinical Trial Phase
Completed NCT02915848 - Long-term Stability of LFP Recorded From the STN and the Effects of DBS
Recruiting NCT03648905 - Clinical Laboratory Evaluation of Chronic Autonomic Failure
Terminated NCT02688465 - Effect of an Apomorphine Pump on the Quality of Sleep in Parkinson's Disease Patients (POMPRENELLE). Phase 4
Completed NCT05040048 - Taxonomy of Neurodegenerative Diseases : Observational Study in Alzheimer's Disease and Parkinson's Disease
Active, not recruiting NCT04006210 - Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations Phase 3
Completed NCT02562768 - A Study of LY3154207 in Healthy Participants and Participants With Parkinson's Disease Phase 1
Completed NCT00105508 - Sarizotan HC1 in Patients With Parkinson's Disease Suffering From Treatment-associated Dyskinesia Phase 3
Completed NCT00105521 - Sarizotan in Participants With Parkinson's Disease Suffering From Treatment Associated Dyskinesia Phase 3
Recruiting NCT06002581 - Repetitive Transcranial Magnetic Stimulation(rTMS) Regulating Slow-wave to Delay the Progression of Parkinson's Disease N/A
Completed NCT02236260 - Evaluation of the Benefit Provided by Acupuncture During a Surgery of Deep Brain Stimulation N/A
Completed NCT00529724 - Body Weight Gain, Parkinson, Subthalamic Stimulation Phase 2
Active, not recruiting NCT05699460 - Pre-Gene Therapy Study in Parkinson's Disease and Multiple System Atrophy
Completed NCT03703570 - A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations Phase 2
Completed NCT03462680 - GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures N/A
Completed NCT02837172 - Diagnosis of PD and PD Progression Using DWI
Not yet recruiting NCT04046276 - Intensity of Aerobic Training and Neuroprotection in Parkinson's Disease N/A
Recruiting NCT02952391 - Assessing Cholinergic Innervation in Parkinson's Disease Using the PET Imaging Marker [18F]Fluoroethoxybenzovesamicol N/A
Active, not recruiting NCT02937324 - The CloudUPDRS Smartphone Software in Parkinson's Study. N/A
Completed NCT02874274 - Vaccination Uptake (VAX) in PD N/A
Terminated NCT02894567 - Evaluation of Directional Recording and Stimulation Using spiderSTN N/A